30 results found.

Congenital Heart Disease Clinical Trial

Pediatrix Medical Group - Recruiting N/A to 30 Days.
- The Impact of Implementing a Universal Newborn Screening for Critical Congenital Heart Disease.

Patients Undergoing Surgery for Congenital Heart Disease Clinical Trial using surgery for congenital heart disease

Samsung Medical Center - Recruiting N/A to 10 years.
- Incidence, Risk Factors, and Risk Model of Acute Kidney Injury in Pediatric Patients Who Undergoing Surgery for Congenital Heart Disease.
surgery for congenital heart disease

Patients Who Underwent Surgery for Congenital Heart Disease Clinical Trial using Surgery for congenital heart disease

Samsung Medical Center - Recruiting N/A to 10 years.
- Influence of Tidal Volume During Mechanical Ventilation on Postoperative Clinical Outcome in Pediatric Patients Undergoing Congenital Heart Surgery.
Surgery for congenital heart disease

Surgery for Congenital Heart Disease, or Pediatric Patients Clinical Trial using surgery for congenital heart disease with cardiopulmonary bypass

Samsung Medical Center - Recruiting N/A to 10 years.
- The Predictability of Intraoperative Rotational Thromboelastometry on Postoperative Bleeding and Transfusion Requirements.
surgery for congenital heart disease with cardiopulmonary bypass

Congenital Heart Disease, Cardiac Catheterization, Brazilian Elec Clinical Trial

Hospital do Coracao - Recruiting N/A or older.
- Phase 0 _ Brazilian Registry of Congenital HeArt Disease INtervention and Angiography.

Congenital Heart Defects Clinical Trial

New England Research Institutes - Recruiting N/A or older.
- Congenital Heart Disease GEnetic NEtwork Study (CHD GENES).

Congenital Heart Disease, Atherosclerosis, Myocardial Ischemia, M Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Suburban/NHLBI Cardiovascular Disease Screening Protocol.

Congenital Heart Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years to 80 years.
- Quantitative Myocardial Perfusion, Myocardial Scarring and Their Contribution to Late Clinical Decompensation in Adults With Congenital Heart Disease.

Caridovascular Disease, Congenital Heart Disease, or Pulmonary Hy Clinical Trial using Balloon catheter for right heart catheterization; Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Right Heart Catheterization; Cardiac Real-time MRI; Vascular Hemostasis

National Institutes of Health Clinical Center (CC) - Recruiting 21 years or older.
- Real-Time MRI Right Heart Catheterization Using Passive Catheters.
Balloon catheter for right heart catheterization; Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Right Heart Catheterization; Cardiac Real-time MRI; Vascular Hemostasis

Eisenmenger Syndrome Clinical Trial using Macitentan 10 mg, oral tablet, to be taken once daily.; Matching placebo oral tablet, to be taken once daily.

Actelion - Recruiting 12 years to 70 years.
- A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group, Phase 3 Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome..
Macitentan 10 mg, oral tablet, to be taken once daily.; Matching placebo oral tablet, to be taken once daily.

Heart Defects, Congenital, Critical Illness, Mental Processes, or Clinical Trial

Katholieke Universiteit Leuven - Recruiting 84 Months to 89 Months.
- Neurocognitive Development in Children With Congenital Heart Disease: Growing Into Deficit.

Congenital Heart Disease, or Disorder of Fetus or Newborn Clinical Trial using Methylprednisolone; Placebo

Medical University of South Carolina - Recruiting N/A to 30 Days.
- Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass.
Methylprednisolone; Placebo

Congenital Heart Disease, or Fontan Clinical Trial using inhaled nitric oxide

University of California, San Francisco - Recruiting 4 years to 60 years.
- The Effect of Selective Pulmonary Vasodilation on Ventricular Afterload and Ventricular-arterial Coupling in Patients With Fontan Physiology and Validation of Echocardiographic Measures of Systolic and Diastolic Function..
inhaled nitric oxide

Congenital Heart Disease, or Heart Disease Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- The Genetic Basis of Congenital Heart Disease in Africa.

Congenital Heart Disease, or Pulmonary Arterial Hypertension Clinical Trial using Sildenafil singly or in association with Bosentan

University of Sao Paulo General Hospital - Recruiting 2 Months or older.
- Combined Clinical and Surgical Approaches to Congenital Heart Disease Associated With Pulmonary Arterial Hypertension (PAH-CHD).
Sildenafil singly or in association with Bosentan

Pulmonary Arterial Hypertension, or Congenital Heart Disease Clinical Trial using observational

Actelion - Recruiting 18 years or older.
- Adult Congenital Heart Disease Quality Enhancement Research Initiative.
observational

Pulmonary Arterial Hypertension, HIV Infection, Congenital Heart Clinical Trial using skin biopsy; Blood Sample

Assistance Publique - H“pitaux de Paris - Recruiting 18 years or older.
- Auto-immunity and Prognosis of Pulmonary Arterial Hypertension.
skin biopsy; Blood Sample

Congenital Heart Disease Clinical Trial using EQUANOX Advance 8004CB sensor

Mayo Clinic - Recruiting N/A to 3 years.
- Does Near Infrared Spectroscopy Predict Low Cardiac Output State in Neonates and Infants Following Cardiac Surgery for Congenital Heart Disease?.
EQUANOX Advance 8004CB sensor

Eisenmenger Syndrome Clinical Trial using Macitentan 10 mg tablet, once daily.

Actelion - Recruiting 12 years to 71 years.
- Long Term, Single-arm, Open-label Extension Study of Protocol AC-055-305 to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Eisenmenger Syndrome.
Macitentan 10 mg tablet, once daily.

Congenital Heart Disease Clinical Trial

Hadassah Medical Organization - Recruiting 18 years to 85 years.
- .

Fluid Overload Clinical Trial using furosemide; ethacrynic acid

Bambino Ges— Hospital and Research Institute - Recruiting N/A to 10 years.
- Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial.
furosemide; ethacrynic acid

Congenital Heart Disease Clinical Trial

Columbia University - Recruiting N/A to 50 years.
- The Prenatal Effects of Congenital Heart Disease on Neurodevelopmental Outcome.

Congenital Heart Defects Clinical Trial using Percutaneous pulmonary valve implantation or open heart surgery

Oslo University Hospital - Recruiting 7 years to 50 years.
- Outcomes in Patients and Their Closest Relatives Treated for Congenital Heart Disease With Catheter Based or Surgical Techniques..
Percutaneous pulmonary valve implantation or open heart surgery

Heart Defects, Congenital Clinical Trial using Structured exercise training

University Hospital, Basel, Switzerland - Recruiting 18 years or older.
- Cardiac Rehabilitation in Patients With Complex Congenital Heart Disease: Improvement of Exercise Intolerance.
Structured exercise training

Congenital Heart Disease Clinical Trial

Emory University - Recruiting N/A or older.
- Congenital Heart Disease Research Registry.

Congenital Heart Disease, Heart Failure, or Endomyocardial Fibros Clinical Trial using Spironolactone; Placebo

Oregon Health and Science University - Recruiting 18 years to 80 years.
- Heart Failure in Congenital Heart Disease: the Role of Myocardial Fibrosis. Treatment Sub-Study: Spironolactone vs. Placebo.
Spironolactone; Placebo

Congenital Heart Disease Clinical Trial using sildenafil citrate

Oslo University Hospital - Recruiting 16 years to 25 years.
- Pulmonary Hypertension in Adolescents and Adults With Congenital Heart Disease.
sildenafil citrate